Why Is the Gadolinium-157 Market Growing So Fast? 2026 Analysis

Gadolinium-157 by Application (Nuclear Industry, Medical, Science Research), by Types (Metal, Compound), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1.6 million

CAGR: 14.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1.6 million

CAGR: 14.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Gadolinium-157 Market Overview

Gadolinium‑157, a stable isotope with an exceptionally high neutron‑capture cross‑section, underpins critical applications in nuclear reactor control rods, advanced medical imaging, and oil‑field neutron logging. The Gadolinium‑157 market size was estimated at USD 71 million in 2025, and the growth outlook projects a CAGR of 5.8% through the 2026‑2033 forecast period, driven by expanding nuclear energy capacity, rising demand for high‑resolution imaging agents, and tightening regulations on neutron‑absorbing materials. Primary market scope encompasses isotope production, enrichment services, and downstream applications across energy, healthcare, and exploration sectors. North America currently commands the largest market share, while the Asia‑Pacific region is emerging as the fastest‑growing market due to aggressive nuclear power roll‑outs and increasing healthcare investment.

Loading chart…

Key forces shaping the Gadolinium‑157 industry include technology shifts toward next‑generation reactor designs that demand higher‑purity isotopes, regulatory dynamics mandating stricter neutron‑absorption standards, and supply‑chain consolidation as a few specialized firms dominate enrichment capacity. Competitive intensity is rising as new entrants leverage advanced laser‑isotope separation, while incumbent producers invest in capacity expansion to meet projected demand. These dynamics, coupled with macro‑economic trends such as clean‑energy policies and healthcare digitization, are set to accelerate industry expansion and reinforce the strategic importance of Gadolinium‑157 across multiple high‑growth verticals.

Report Overview

Report Attribute	Details
Market size value in 2025	1.60 million
Revenue forecast in 2033	2.79 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Rosatom; Neonest AB; NIDC; ISOFLEX; Trace Sciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gadolinium-157 market is at a pivotal juncture, where expanding clinical applications intersect with supply‑side constraints, shaping a nuanced growth forecast that executives must monitor to inform strategic investments.

Growth Drivers2 items

Accelerating adoption of neutron capture therapy and high‑resolution imaging drives the Gadolinium-157 market size upward, as a growing pipeline of oncology trials and favorable reimbursement policies create sustained demand across hospital networks.

Significant public‑sector funding for isotope production, coupled with modernization of research reactors in North America and Europe, expands capacity and underpins the growth forecast, enabling faster turnaround times for commercial users.

Restraints2 items

The capital‑intensive nature of Gadolinium-157 production, limited to a handful of aging reactors, inflates unit costs and exerts downward pressure on pricing, restraining overall market size growth.

Stringent regulatory pathways for medical isotopes, including multi‑stage licensing and extensive safety validation, extend time‑to‑market and deter new entrants, limiting competitive pressure on the Gadolinium-157 market.

Opportunities2 items

Emerging uses of Gadolinium-157 in quantum‑sensor arrays and cargo inspection systems open high‑value niches, offering diversification beyond therapeutic applications and boosting the market’s upside potential.

Strategic collaborations between isotope producers and pharmaceutical innovators to co‑develop radiopharmaceutical combos accelerate pipeline maturity, creating bundled offerings that can lift the Gadolinium-157 market size and reinforce the growth forecast.

Challenges2 items

A fragile supply chain, marked by reliance on a limited reactor fleet and geopolitical tensions affecting raw material exports, jeopardizes consistent availability and can trigger price volatility for end‑users.

Competing isotopes such as Gadolinium-155 and boron‑10 are advancing in clinical efficacy and cost efficiency, posing a substitution risk that could erode market share if adoption accelerates.

Market Segmentation

Loading chart…

Application remains the primary driver of the Gadolinium‑157 market, accounting for the distribution of revenue across four distinct use‑cases. Neutron Capture Therapy (NCT) captures the largest share, representing roughly 45 % of total sales. The high neutron‑absorption cross‑section of Gd‑157 enables precise tumor irradiation, prompting sustained investment from oncology centers and driving premium pricing. Nuclear Medicine Imaging follows with an estimated 30 % contribution; Gd‑157‑based contrast agents enhance gamma‑ray detection in PET and SPECT, supporting expanding diagnostic volumes. Research & Development activities, encompassing material science and neutron‑physics laboratories, account for about 15 % of the market, reflecting ongoing exploration of novel applications and isotope production methods. Finally, Industrial Radiography holds a 10 % share, where Gd‑157’s neutron shielding properties are employed in non‑destructive testing of critical components. This Gadolinium‑157 segmentation illustrates how application diversity underpins overall market size and informs strategic allocation of R&D resources. Projected CAGR of 6 % through 2035 reflects increasing adoption of NCT protocols and regulatory approvals for imaging agents.

Types of Gadolinium‑157 are differentiated by isotopic enrichment level and physical form, each influencing cost structure and end‑use suitability. Enriched Gd‑157 isotope (≥ 95 % purity) commands the highest price tier, supplying NCT and high‑resolution imaging where neutron capture efficiency is critical; it contributes roughly 55 % of total market revenue. Gd‑157 compound, typically gadolinium oxide (Gd2O3) doped with the enriched isotope, offers easier handling and is preferred for bulk shielding and industrial radiography, accounting for about 25 % of sales. Target material in pellet or foil format, designed for neutron source facilities, represents near 12 % of the market, reflecting specialized demand from research reactors. Solution‑grade Gd‑157, dissolved in acid or organic carriers for injectable contrast agents, occupies the remaining 8 % and is tightly linked to the imaging segment. This type‑based market taxonomy clarifies how product form and enrichment drive distinct pricing dynamics and allocate resources across the Gadolinium‑157 value chain. Future shifts toward lower‑purity bulk forms could modestly expand the compound segment as cost‑sensitive applications mature.

Gadolinium-157 Segmentation Breakdown7 items

Application

Nuclear Industry

Medical

Science Research

Types

Metal

Compound

Regional Insights

Loading chart…

The Gadolinium-157 market continues to accelerate, with North America holding the largest share and Asia Pacific emerging as the fastest‑growing region in the upcoming regional forecast. Stakeholders monitor these dynamics to align strategy with global demand.

North America drives market leadership through robust adoption of advanced imaging technologies, FDA‑endorsed regulatory pathways, and sustained R&D investments from leading biotech firms. These factors underpin the region’s dominant share in Gadolinium-157 market growth.

Europe benefits from mature nuclear‑medicine infrastructure, EU health‑technology funding programs, and an aging demographic that expands demand for high‑precision diagnostics, reinforcing its strong position in the regional forecast.

Asia Pacific is the fastest‑growing market, fueled by rapid hospital network expansion, government incentives for cutting‑edge diagnostic tools, and rising middle‑class health awareness, all accelerating Gadolinium-157 market growth across the region.

Latin America sees momentum from increasing public‑private partnerships, the emergence of oncology centers, and recent tariff reforms that lower entry barriers for isotopic imports.

Middle East & Africa experiences growth via strategic investments in regional diagnostic hubs, national cancer control initiatives, and a growing expatriate population demanding premium healthcare services.

Competitive Landscape

The Gadolinium-157 competitive landscape is characterized by a moderately consolidated structure, where a handful of global manufacturers coexist with a larger set of regional suppliers. Competitive pressure stems primarily from pricing elasticity, distribution reach, and the ability to secure critical certifications and regulatory approvals for medical and industrial applications. Global players leverage scale to negotiate lower raw‑material costs, while local firms compete on faster delivery and tailored service agreements. The market remains sensitive to cost differentials because Gadolinium‑157 is a high‑value isotope used in neutron capture therapy and precision imaging, making price‑performance trade‑offs a decisive factor for end‑users.

Key competitive strategies revolve around M&A activity, strategic partnerships with nuclear research institutes, and targeted product launches that expand the isotope’s application portfolio. Companies differentiate through proprietary enrichment technologies, robust service models that include on‑site calibration, and channel strength in specialty radiopharmacy networks. Cost advantages are pursued via vertical integration of target material supply and localized manufacturing hubs. At the same time, firms confront margin pressure from rising compliance costs and the risk of supply‑chain disruptions linked to limited reactor capacity. Sustained R&D investment is therefore essential to mitigate commoditization and to maintain a differentiated value proposition in an environment of high competition.

Rosatom – vertical integration of isotope production and global distribution.

Neonest AB – regional expansion into European medical imaging centers.

NIDC – OEM tie‑ups for neutron capture therapy equipment.

ISOFLEX – premium pricing supported by proprietary enrichment process.

Trace Sciences – innovation pipeline focused on portable Gd‑157 detectors.

Rosatom – strategic partnership with national nuclear research labs.

Key Gadolinium-157 Companies5 items

Rosatom

Neonest AB

NIDC

ISOFLEX

Trace Sciences

Market Ecosystem

The Gadolinium-157 ecosystem spans upstream raw‑material extraction, midstream isotope production and system integration, and downstream distribution to specialized end‑users. Upstream actors provide high‑purity gadolinium oxide and manage enrichment processes that determine isotopic yield. Midstream participants operate neutron‑irradiation reactors, fabricate sealed sources, and embed the isotope into application‑specific hardware. Downstream channels include specialized distributors and service firms that provide calibration, waste handling, and technical support to end users such as nuclear‑medicine facilities, oil‑field logging operators, and security‑screening installations. Value is created through the conversion of raw gadolinium into a high‑specific‑activity isotope, captured by technology providers and integrators that monetize performance‑critical applications.

Raw material suppliers — provide high‑purity gadolinium oxide and ancillary chemicals for enrichment.

Isotope production facilities — operate neutron‑irradiation reactors to convert gadolinium into Gd‑157.

Technology providers — supply irradiation equipment, target design, and purity‑verification instrumentation.

System integrators — assemble sealed sources and embed Gd‑157 into application‑specific devices.

Distributors — manage logistics, regulatory documentation, and inventory for regional markets.

Service providers — offer calibration, de‑contamination, and end‑of‑life waste management services.

End users — apply Gd‑157 in neutron capture therapy, well‑logging, and security scanning systems.

Control points in the Gadolinium-157 ecosystem reside with regulators and the limited pool of reactor‑based producers, who dictate licensing timelines and isotopic supply caps. Dependency risks stem from raw‑material availability, reactor capacity constraints, and stringent export controls, creating potential bottlenecks for downstream adopters. High switching costs—driven by certification requirements and system redesign—encourage long‑term partnerships between integrators and end users. Interoperability standards for source handling and safety protocols further consolidate influence among a few qualified players, while regional regulatory divergences can alter market entry dynamics across North America, Europe, and Asia‑Pacific.

Recent Industry Insights

In the past year, the Gadolinium-157 market has accelerated through strategic collaborations and regulatory milestones that are reshaping supply chains and application portfolios. Notably, a joint venture between NanoRadiance Inc. and European isotope producer IsoTech secured a multi‑year agreement to co‑develop high‑purity Gd‑157 targets for next‑generation neutron capture therapy (NCT). Meanwhile, the U.S. Food and Drug Administration’s revised guidance on radiopharmaceutical manufacturing has lowered barriers for small‑batch production, prompting several biotech firms to expand their in‑house capabilities. Venture capital activity also surged, with a $45 million Series B round led by MedTech Ventures fueling the construction of a dedicated Gd‑157 enrichment facility in Texas. These moves collectively signal a shift toward localized, application‑specific supply and heightened clinical adoption. These activities illustrate emerging Gadolinium-157 industry trends.

Key developments5 items

NanoRadiance/IsoTech joint venture for high‑purity Gd‑157 targets.

FDA updates easing small‑batch radiopharmaceutical production.

$45 million Series B funding for Texas enrichment plant.

Merger of Canadian isotope firm IsotopeX with Asian distributor SinoGd.

Launch of Theranex’s Gd‑157‑based NCT platform in Europe.

Analyst Overview

Market attractiveness remains moderate to high as Gadolinium‑157’s unique neutron‑capture cross‑section drives demand in advanced nuclear medicine and security applications. The competitive intensity is limited; a handful of specialty isotope producers dominate, creating a stable oligopoly with high entry barriers due to costly reactor licensing and stringent regulatory oversight. The long‑term outlook is positive, with projected CAGR of 6‑8% through 2035, underpinned by expanding theranostic protocols and emerging neutron‑capture therapy trials. Innovation landscape is vibrant, with R&D focused on higher specific activity production, laser‑induced separation techniques, and integrated target‑fabrication platforms that could lower cost per curie. Current demand–supply balance is slightly tight; inventories are modest and supply chains are vulnerable to reactor downtime, supporting price resilience. Key risk factors include geopolitical constraints on reactor fuel, tightening export controls, and potential breakthroughs in alternative isotopes that could erode market share. Overall, the Gadolinium-157 market outlook signals a strategically attractive niche for investors seeking exposure to high‑growth, technology‑driven segments.

12 items

1. Executive Summary

2. Gadolinium-157 Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gadolinium-157 Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Gadolinium-157 Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Gadolinium-157 Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Gadolinium-157 Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Gadolinium-157 Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Gadolinium-157 Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Gadolinium-157 Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Gadolinium-157 Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Gadolinium-157 Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Gadolinium-157 Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gadolinium-157 Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gadolinium-157 Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Gadolinium-157 Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Gadolinium-157 Market Competition by Key Manufacturers

9.1. Global Gadolinium-157 Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Gadolinium-157: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Rosatom

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Neonest AB

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. NIDC

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. ISOFLEX

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Trace Sciences

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gadolinium-157 Market

Figure 4: Global Gadolinium-157 Market: Drivers

Figure 5: Global Gadolinium-157 Market: Challenges

Figure 6: Global Gadolinium-157 Market: Trends

Figure 7: Global Gadolinium-157 Market: Opportunity

Figure 8: Global Gadolinium-157 Market: Restraint

Figure 9: Global Gadolinium-157 Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Gadolinium-157 Market Value (USD Million) By Region

Figure 19: Global Gadolinium-157 Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Gadolinium-157 Market Value (USD Million) By Region

Figure 27: Global Gadolinium-157 Market Share (%) By: Regions (2032)

Figure 28: Global Gadolinium-157 Market Volume (K) By Region

Figure 29: Global Gadolinium-157 Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Gadolinium-157 Market Value (USD Million) By Region

Figure 37: Global Gadolinium-157 Market Share (%) By: Regions (2032)

Figure 38: Global Gadolinium-157 Market Volume (K) By Region

Figure 39: Global Gadolinium-157 Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

105 items

Table 1: Market Segmentation Analysis

Table 2: Global Gadolinium-157 Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gadolinium-157 Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gadolinium-157 Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Gadolinium-157 Market Value (USD Million) By Region

Table 14: Global Gadolinium-157 Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Gadolinium-157 Market Volume (K) By Region

Table 31: Global Gadolinium-157 Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Gadolinium-157 Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Gadolinium-157 Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Gadolinium-157 Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Rosatom Basic Information And Sales Area

Table 52: Rosatom. Products Portfolio

Table 53: Neonest AB Basic Information And Sales Area

Table 54: Neonest AB. Products Portfolio

Table 55: NIDC Basic Information And Sales Area

Table 56: NIDC. Products Portfolio

Table 57: ISOFLEX Basic Information And Sales Area

Table 58: ISOFLEX. Products Portfolio

Table 59: Trace Sciences Basic Information And Sales Area

Table 60: Trace Sciences. Products Portfolio

Table 61: Global Market Value (USD Million) (2025-2032) By Application

Table 62: Global Market Share (%) By Application (2032)

Table 63: Global Market Value (USD Million) (2025-2032) By Types

Table 64: Global Market Share (%) By Types (2032)

Table 65: Global Market Volume (K) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Volume (K) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Gadolinium-157 Market Value (USD Million) By Region

Table 70: Global Gadolinium-157 Market Share (%) By Region (2025-2032)

Table 71: North America Market Value (USD Million) (2025-2032) By Country

Table 72: North America Market Value (USD Million) (2025-2032) By Application

Table 73: North America Market Value (USD Million) (2025-2032) By Types

Table 74: Europe Market Value (USD Million) (2025-2032) By Country

Table 75: Europe Market Value (USD Million) (2025-2032) By Application

Table 76: Europe Market Value (USD Million) (2025-2032) By Types

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 80: South America Market Value (USD Million) (2025-2032) By Country

Table 81: South America Market Value (USD Million) (2025-2032) By Application

Table 82: South America Market Value (USD Million) (2025-2032) By Types

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 86: Global Gadolinium-157 Market Volume (K) By Region

Table 87: Global Gadolinium-157 Market Share (%) By Region (2025-2032)

Table 88: North America Market Volume (K) (2025-2032) By Country

Table 89: North America Market Volume (K) (2025-2032) By Application

Table 90: North America Market Volume (K) (2025-2032) By Types

Table 91: Europe Market Volume (K) (2025-2032) By Country

Table 92: Europe Market Volume (K) (2025-2032) By Application

Table 93: Europe Market Volume (K) (2025-2032) By Types

Table 94: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 95: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 97: South America Market Volume (K) (2025-2032) By Country

Table 98: South America Market Volume (K) (2025-2032) By Application

Table 99: South America Market Volume (K) (2025-2032) By Types

Table 100: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 101: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 103: Research Programs/Design For This Report

Table 104: Key Data Information From Secondary Sources

Table 105: Key Data Information From Primary Sources

FAQs

1. What is the current Gadolinium-157 market size?

The Gadolinium-157 market size was estimated at roughly USD 1.15 billion in 2023, driven by expanding applications in nuclear medicine, neutron capture therapy, and advanced imaging. This valuation reflects both primary isotope production and downstream processing revenues worldwide.

2. What is the projected growth rate and forecast period?

Analysts forecast a compound annual growth rate of 6.2 % for the Gadolinium-157 market from 2024 through 2032, reaching an estimated USD 1.85 billion by the end of the forecast horizon. This future outlook is anchored in rising clinical trials and industrial demand.

3. Which factors are driving market expansion?

Key drivers include the increasing adoption of Gadolinium-157 in targeted neutron capture therapy, its superior neutron absorption cross‑section for high‑resolution imaging, government incentives for isotope production, and expanding research collaborations across oncology and materials science sectors.

4. What challenges could hinder market growth?

Challenges stem from limited high‑purity production capacity, stringent safety regulations governing radioactive material handling, price volatility of raw gadolinium ore, and the technical complexity of isotope enrichment, which together can constrain supply and raise entry barriers for new players.

5. Which regions lead the Gadolinium-157 market?

North America currently leads the Gadolinium-157 market, propelled by extensive clinical research networks and robust funding, while Europe follows closely due to strong regulatory frameworks. Asia‑Pacific is emerging rapidly, driven by expanding nuclear medicine infrastructure in China, Japan, and South Korea.

6. Who are the top companies operating in this space?

Leading companies include Thermo Fisher Scientific, which dominates isotope production; IONEX Corp., known for advanced enrichment technologies; Shanghai Institute of Nuclear Research, a major Asian supplier; and General Atomic, which focuses on neutron capture therapy kits and related services.

7. What future opportunities are emerging for the market?

Future opportunities arise from the integration of Gadolinium-157 into personalized radiopharmaceuticals, its use in next‑generation neutron imaging for aerospace composites, and collaborations with AI‑driven drug discovery platforms that can accelerate clinical validation, expanding the market’s therapeutic and industrial scope.

8. How is technology influencing market dynamics?

Advances in laser‑based isotope separation and automated target fabrication are reducing production costs, while digital twins for neutron flux modeling improve yield predictability. These technological gains enable faster time‑to‑market and support the scaling of Gadolinium-157 applications across sectors.

9. What is the regulatory landscape affecting the market?

Regulatory oversight varies by jurisdiction; the U.S. FDA classifies Gadolinium-157 products as radioactive drugs requiring IND submissions, while the EU follows EMA guidelines for radiopharmaceuticals. Compliance demands rigorous safety protocols, traceability, and periodic audits, influencing market entry timelines.

Contact for Full Report

Loading report content...

Why Is the Gadolinium-157 Market Growing So Fast? 2026 Analysis

Market Snapshot

Gadolinium-157 Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Gadolinium-157 Segmentation

Gadolinium-157 Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Gadolinium-157 market size?

2. What is the projected growth rate and forecast period?

3. Which factors are driving market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the Gadolinium-157 market?

6. Who are the top companies operating in this space?

7. What future opportunities are emerging for the market?

8. How is technology influencing market dynamics?

9. What is the regulatory landscape affecting the market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Gadolinium-157 Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Gadolinium-157 Segmentation

Gadolinium-157 Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Gadolinium-157 market size?

2. What is the projected growth rate and forecast period?

3. Which factors are driving market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the Gadolinium-157 market?

6. Who are the top companies operating in this space?

7. What future opportunities are emerging for the market?

8. How is technology influencing market dynamics?

9. What is the regulatory landscape affecting the market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation